RR No. 6-2020 exempts qualified COVID-19 healthcare imports, inputs, and donations from VAT, excise tax, other fees, and donor’s tax.

Importers, manufacturers, donors, hospitals, government suppliers, and businesses supporting the COVID-19 response received immediate tax relief under RR No. 6-2020: qualified healthcare imports, inputs for producing emergency health supplies, and certain donations were made exempt from VAT, excise tax, other fees, and donor’s tax during the effectivity of Republic Act No. 11469, or the Bayanihan to Heal as One Act. The most urgent compliance point is equally practical: covered imports may be released by the Bureau of Customs without an Authority to Release Imported Goods, but importers must still ensure that their goods fall squarely within the regulation because the BIR may conduct a post-investigation audit.

What RR No. 6-2020 Changed

RR No. 6-2020 implemented the tax exemption provision of Republic Act No. 11469, specifically the Bayanihan to Heal as One Act rule liberalizing incentives for the manufacture or importation of critical or needed equipment and supplies for carrying out the declared national policy against COVID-19.

The regulation declared that importation of critical or needed healthcare equipment or supplies intended to combat the COVID-19 public health emergency is exempt from value-added tax, excise tax, and other fees. This exemption covers specific emergency healthcare goods, including personal protective equipment, laboratory equipment, medical equipment, supplies, consumables, and COVID-19 testing kits.

RR No. 6-2020 also extended the exemption to importation of materials needed to make health equipment and supplies deemed as critical or needed to address the current public health emergency. These inputs must be included in the Master List of the Department of Trade and Industry and other incentive-granting bodies.

For businesses, this changed the cost and release mechanics of COVID-19 response goods. Instead of treating importation of covered supplies as ordinary taxable importation, the regulation allowed qualifying items to enter free from VAT, excise tax, and other fees during the Bayanihan emergency period.

Who Is Most Affected by RR No. 6-2020

The regulation is most relevant to importers of medical supplies, manufacturers of healthcare equipment, distributors of COVID-19 emergency goods, hospitals, laboratories, logistics providers, donors, and companies coordinating with government agencies during the COVID-19 emergency.

Corporate accountants and CFOs should pay particular attention if their companies imported PPE, testing kits, laboratory supplies, alcohol, sanitizers, medicines, or raw materials used to manufacture health equipment during the covered period. Tax managers should also review whether the company treated exempt importations properly for VAT, excise tax, customs release, and documentary support purposes.

Suppliers and donors dealing with the National Government, government agencies, government-created non-profit entities, and political subdivisions are also affected because RR No. 6-2020 separately addressed donations of imported articles and their treatment for donor’s tax and deductibility purposes.

Healthcare Equipment and Supplies Covered by the Tax Exemption

RR No. 6-2020 expressly covered importation of critical or needed healthcare equipment or supplies intended to combat the COVID-19 public health emergency. These include personal protective equipment such as gloves, gowns, masks, goggles, and face shields.

The exemption also covers surgical equipment and supplies; laboratory equipment and its reagents; medical equipment and devices; support and maintenance for laboratory and medical equipment; surgical equipment and supplies; and medical supplies, tools, and consumables.

Specific medical supplies and consumables listed in the regulation include alcohol, sanitizers, tissue, thermometers, soap, detergent, sodium hypochlorite, cleaning materials, povidone iodine, and common medicines. The regulation specifically mentions paracetamol tablets and suspension, mefenamic acid, vitamins tablets and suspension, hyoscine tablets and suspension, oral rehydration solution, and cetirizine tablets and suspension.

COVID-19 testing kits are also covered, together with other supplies or equipment that may be determined by the Department of Health and other relevant government agencies. This means companies should not rely only on generic descriptions such as “medical supplies” or “COVID items”; they should identify whether the specific product is covered by the listed categories or has been determined as covered by the relevant government agency.

Exemption for Raw Materials Used to Make Health Equipment and Supplies

RR No. 6-2020 did not limit tax relief to finished medical goods. It also covered importation of materials needed to make health equipment and supplies deemed as critical or needed to address the COVID-19 public health emergency.

However, the regulation included an important qualification: these materials must be included in the Master List of the Department of Trade and Industry and other incentive-granting bodies. Manufacturers and importers should therefore maintain documentation showing not only that the imported materials were intended for health equipment or supplies, but also that the materials were covered by the relevant list or authority.

No ATRIG Required for Covered Importations

One of the most practical changes under RR No. 6-2020 is that covered importations are not subject to the issuance of an Authority to Release Imported Goods under Revenue Memorandum Order No. 35-2002.

For covered COVID-19 healthcare imports, the ATRIG was not necessary for release from the Bureau of Customs. This was a major administrative relief because ATRIG requirements can delay customs release where internal revenue taxes are involved.

However, the absence of an ATRIG requirement does not mean absence of scrutiny. RR No. 6-2020 states that, based on the Bureau of Customs list of importers who made importations without any ATRIG, the BIR will conduct a post-investigation audit. Importers should therefore prepare contemporaneous records proving that the goods were covered by the exemption, were imported during the effective period, and were intended for the COVID-19 public health emergency.

Donor’s Tax Exemption and Deductibility of Donations

RR No. 6-2020 also provided tax relief for donations involving the covered imported articles. Donations of these imported articles to, or for the use of, the National Government or any entity created by any of its agencies which is not conducted for profit, or to any political subdivision of the government, are exempt from donor’s tax.

The regulation further states that these donations are subject to the ordinary rules of deductibility under existing rules and issuances. This point matters for corporate donors because donor’s tax exemption and income tax deductibility are separate tax questions. A donation may be exempt from donor’s tax, but the taxpayer should still substantiate deductibility in accordance with applicable BIR rules on donations, documentation, and allowable deductions.

Effectivity and Deadline Period

RR No. 6-2020 took effect immediately. Its relief remained in full force only during the three-month effectivity period of Republic Act No. 11469, otherwise known as the Bayanihan to Heal as One Act, unless extended or withdrawn by Congress or ended by Presidential Proclamation.

For businesses reviewing past importations, the timing of the transaction is critical. The exemption was not an open-ended COVID-19 tax holiday. It was tied to the statutory emergency period under RA No. 11469. Accountants and tax managers should therefore match import entries, customs release documents, invoices, donation records, and internal approvals against the Bayanihan Act effectivity period.

Penalties and Audit Risk for Non-Compliance

RR No. 6-2020 does not create a separate penalty schedule. However, it expressly warns that the BIR will conduct a post-investigation audit based on Bureau of Customs records of importers who released goods without an ATRIG.

The practical risk is that an importer who improperly claimed exemption for goods not covered by RR No. 6-2020 may later face assessment for taxes and applicable additions under existing tax rules. The audit risk is especially important where the goods were described broadly, where the importer relied on COVID-related use without product-level support, or where imported raw materials were not shown to be covered by the DTI Master List or other incentive-granting bodies.

Practical Steps for Businesses, CFOs, and Tax Managers

Businesses that imported COVID-19 healthcare supplies or manufacturing inputs during the Bayanihan emergency period should review the import documents and classify the goods against the exact categories in RR No. 6-2020. The review should cover PPE, surgical equipment, laboratory equipment and reagents, medical devices, support and maintenance items, medical consumables, common medicines, and testing kits.

Manufacturers should verify whether imported inputs were included in the Master List of the Department of Trade and Industry or other incentive-granting bodies. This is particularly important where the imported item was not itself a finished medical supply but was used to produce critical health equipment or supplies.

Importers should also preserve customs entries, invoices, bills of lading, supplier descriptions, product specifications, government certifications, proof of emergency use, and internal records supporting the exemption. Companies that released goods without ATRIG should assume that BIR review remains possible and should prepare the file before any audit notice arrives.

Corporate donors should separately document the recipient, the nature of the imported articles donated, the government or qualifying non-profit status of the recipient, and the basis for donor’s tax exemption. They should also coordinate the deductibility treatment with their accountants because RR No. 6-2020 refers donations to ordinary deductibility rules under existing issuances.

Why Legal Review Matters for RR No. 6-2020 Compliance

RR No. 6-2020 is short, but its application can be sensitive because it combines customs release, VAT exemption, excise tax exemption, donor’s tax exemption, ATRIG relief, and post-audit exposure. The key question for businesses is not merely whether the goods were pandemic-related, but whether they fall within the specific exemption framework of RA No. 11469 and RR No. 6-2020.

Ablola, Saribong & Gueco assists businesses, importers, manufacturers, donors, and corporate finance teams in reviewing BIR compliance, tax exemption support, customs-related tax issues, donation documentation, and audit defense. For guidance on RR No. 6-2020, Bayanihan Act tax exemptions, ATRIG issues, VAT and excise tax exposure, or BIR audit preparation, contact Ablola, Saribong & Gueco through MakatiLawFirm.com.


Leave a Comment

Your email address will not be published. Required fields are marked *